382 related articles for article (PubMed ID: 11737597)
1. Podocyte expression of the CDK-inhibitor p57 during development and disease.
Hiromura K; Haseley LA; Zhang P; Monkawa T; Durvasula R; Petermann AT; Alpers CE; Mundel P; Shankland SJ
Kidney Int; 2001 Dec; 60(6):2235-46. PubMed ID: 11737597
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of d-type cyclins in podocytes in vitro and in vivo.
Petermann A; Hiromura K; Pippin J; Blonski M; Couser WG; Kopp J; Mundel P; Shankland SJ
Am J Pathol; 2004 Apr; 164(4):1417-24. PubMed ID: 15039229
[TBL] [Abstract][Full Text] [Related]
4. Mechanical stress reduces podocyte proliferation in vitro.
Petermann AT; Hiromura K; Blonski M; Pippin J; Monkawa T; Durvasula R; Couser WG; Shankland SJ
Kidney Int; 2002 Jan; 61(1):40-50. PubMed ID: 11786083
[TBL] [Abstract][Full Text] [Related]
5. Cell-cycle regulatory proteins in podocyte cell in idiopathic nephrotic syndrome of childhood.
Srivastava T; Garola RE; Whiting JM; Alon US
Kidney Int; 2003 Apr; 63(4):1374-81. PubMed ID: 12631353
[TBL] [Abstract][Full Text] [Related]
6. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies.
Barisoni L; Mokrzycki M; Sablay L; Nagata M; Yamase H; Mundel P
Kidney Int; 2000 Jul; 58(1):137-43. PubMed ID: 10886558
[TBL] [Abstract][Full Text] [Related]
7. Expression of the cyclin kinase inhibitor, p27kip1, in developing and mature human kidney.
Combs HL; Shankland SJ; Setzer SV; Hudkins KL; Alpers CE
Kidney Int; 1998 Apr; 53(4):892-6. PubMed ID: 9551395
[TBL] [Abstract][Full Text] [Related]
8. The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis.
Kim YG; Alpers CE; Brugarolas J; Johnson RJ; Couser WG; Shankland SJ
Kidney Int; 1999 Jun; 55(6):2349-61. PubMed ID: 10354282
[TBL] [Abstract][Full Text] [Related]
9. Expression and activity of the CDK inhibitor p57Kip2 in chondrocytes undergoing hypertrophic differentiation.
Stewart MC; Kadlcek RM; Robbins PD; MacLeod JN; Ballock RT
J Bone Miner Res; 2004 Jan; 19(1):123-32. PubMed ID: 14753744
[TBL] [Abstract][Full Text] [Related]
10. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
Srivastava T; Garola RE; Singh HK
Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
[TBL] [Abstract][Full Text] [Related]
11. Cell-cycle mechanisms involved in podocyte proliferation in cellular lesion of focal segmental glomerulosclerosis.
Wang S; Kim JH; Moon KC; Hong HK; Lee HS
Am J Kidney Dis; 2004 Jan; 43(1):19-27. PubMed ID: 14712423
[TBL] [Abstract][Full Text] [Related]
12. Glomerular differentiation in p27 and p57 double-mutant metanephroi.
Tomari S; Nagahama H; Shu Y; Hoshi S; Nakayama K; Nakayama KI; Nagata M
Anat Embryol (Berl); 2002 Dec; 206(1-2):31-6. PubMed ID: 12478365
[TBL] [Abstract][Full Text] [Related]
13. Mechanical stretch induces podocyte hypertrophy in vitro.
Petermann AT; Pippin J; Durvasula R; Pichler R; Hiromura K; Monkawa T; Couser WG; Shankland SJ
Kidney Int; 2005 Jan; 67(1):157-66. PubMed ID: 15610239
[TBL] [Abstract][Full Text] [Related]
14. Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth.
Ilyin GP; Glaise D; Gilot D; Baffet G; Guguen-Guillouzo C
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G115-27. PubMed ID: 12646420
[TBL] [Abstract][Full Text] [Related]
15. Development of mice without Cip/Kip CDK inhibitors.
Tateishi Y; Matsumoto A; Kanie T; Hara E; Nakayama K; Nakayama KI
Biochem Biophys Res Commun; 2012 Oct; 427(2):285-92. PubMed ID: 23000166
[TBL] [Abstract][Full Text] [Related]
16. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
[TBL] [Abstract][Full Text] [Related]
17. R-roscovitine (CYC202) alleviates renal cell proliferation in nephritis without aggravating podocyte injury.
Milovanceva-Popovska M; Kunter U; Ostendorf T; Petermann A; Rong S; Eitner F; Kerjaschki D; Barnett A; Floege J
Kidney Int; 2005 Apr; 67(4):1362-70. PubMed ID: 15780088
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression.
Qiao L; Leach K; McKinstry R; Gilfor D; Yacoub A; Park JS; Grant S; Hylemon PB; Fisher PB; Dent P
Hepatology; 2001 Nov; 34(5):906-17. PubMed ID: 11679961
[TBL] [Abstract][Full Text] [Related]
19. Effect of Smad pathway activation on podocyte cell cycle regulation: an immunohistochemical evaluation.
Koutroutsos K; Kassimatis TI; Nomikos A; Giannopoulou I; Theohari I; Nakopoulou L
Ren Fail; 2014 Sep; 36(8):1310-6. PubMed ID: 25026939
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle regulation and differentiation in the human podocyte lineage.
Nagata M; Nakayama K; Terada Y; Hoshi S; Watanabe T
Am J Pathol; 1998 Nov; 153(5):1511-20. PubMed ID: 9811343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
